ホーム>>Signaling Pathways>> Cell Cycle/Checkpoint>> Inositol Phosphates>>D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt)

D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) (Synonyms: Ins(1,3,4,6)P4, 1,3,4,6IP4)

カタログ番号GC43517

イノシトールリン酸(IP)は、環状イノシトール構造の6つの炭素それぞれのリン酸化状態を変化させることによって生成される分子群です。

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) 化学構造

Cas No.: 142507-74-2

サイズ 価格 在庫数 個数
100μg
$77.00
在庫あり
500μg
$348.00
在庫あり
1mg
$616.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The inositol phosphates (IPs) are a family of molecules produced by altering the phosphorylation status of each of the six carbons on the cyclic inositol structure. They act as second messengers, regulating a wide array of cellular functions. D-myo-inositol-1,3,4,6-tetraphosphate(Ins(1,3,4,6)-P4) largely acts an intermediate, serving as substrate for inositol-1,3,4,6-tetraphosphate 5-kinase to produce inositol-1,3,4,5,6-pentaphosphate, or inositol-1,3,4,6-tetraphosphate 2-kinase to give inositol-1,2,3,4,6-pentaphosphate. These inositol pentaphosphates can be further phosphorylated to produce inositol-1,2,3,4,5,6-hexakisphosphate, or phytic acid, which serves diverse roles in eukaryotic tissues. Ins(1,3,4,6)-P4 is a poor activator of the inositol 1,4,5-trisphospate receptor in vitro. Other functions of this IP remain to be elucidated.

レビュー

Review for D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.